Davis R M Inc Abbott Laboratories Transaction History

Davis R M Inc

$5.09 Billion
Q3 2024

A detailed history of Davis R M Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Davis R M Inc holds 25,645 shares of ABT stock, worth $3.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

25,645

Previous 28,097 8.73%

Holding current value

$3.3 Million

Previous $2.92 Million 0.14%

% of portfolio

0.06%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $245,371 - $289,654	-2,452 Reduced 8.73%	25,645 $2.92 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $118,357 - $132,117	-1,175 Reduced 4.01%	28,097 $2.92 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $21,904 - $24,192	200 Added 0.69%	29,272 $3.33 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $164,596 - $201,480	-1,825 Reduced 5.91%	29,072 $3.2 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $146,256 - $175,483	-1,531 Reduced 4.72%	30,897 $2.99 Million
Q2 2023 Aug 10, 2023	SELL	$100.78 - $112.29 $54,018 - $60,187	-536 Reduced 1.63%	32,428 $3.54 Million
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $121,946 - $143,538	-1,259 Reduced 3.68%	32,964 $3.34 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $54,184 - $63,566	-570 Reduced 1.64%	34,223 $3.76 Million
Q3 2022 Nov 08, 2022	BUY	$96.76 - $112.03 $545,919 - $632,073	5,642 Added 19.35%	34,793 $3.37 Million
Q2 2022 Aug 08, 2022	BUY	$102.07 - $123.37 $51,341 - $62,055	503 Added 1.76%	29,151 $3.17 Million
Q1 2022 May 05, 2022	BUY	$114.02 - $139.04 $195,772 - $238,731	1,717 Added 6.38%	28,648 $3.39 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $26,225 - $32,111	227 Added 0.85%	26,931 $3.79 Million
Q3 2021 Nov 08, 2021	SELL	$116.66 - $129.06 $79,678 - $88,147	-683 Reduced 2.49%	26,704 $3.16 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $59,982 - $70,608	-567 Reduced 2.03%	27,387 $3.18 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $72,705 - $85,657	-668 Reduced 2.33%	27,954 $3.35 Million
Q4 2020 Jan 27, 2021	BUY	$105.0 - $114.42 $296,310 - $322,893	2,822 Added 10.94%	28,622 $3.13 Million
Q3 2020 Dec 01, 2020	BUY	$91.64 - $111.29 $92,464 - $112,291	1,009 Added 4.07%	25,800 $2.81 Million
Q2 2020 Jul 20, 2020	SELL	$76.57 - $98.0 $41,347 - $52,920	-540 Reduced 2.13%	24,791 $2.27 Million
Q1 2020 Apr 24, 2020	SELL	$62.82 - $91.86 $112,133 - $163,970	-1,785 Reduced 6.58%	25,331 $2 Million
Q4 2019 Jan 23, 2020	SELL	$78.51 - $87.4 $3,454 - $3,845	-44 Reduced 0.16%	27,116 $2.36 Million
Q3 2019 Oct 24, 2019	SELL	$81.84 - $88.74 $196,907 - $213,508	-2,406 Reduced 8.14%	27,160 $2.27 Million
Q2 2019 Jul 31, 2019	SELL	$72.88 - $85.0 $43,436 - $50,660	-596 Reduced 1.98%	29,566 $2.49 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $176,939 - $213,920	-2,672 Reduced 8.14%	30,162 $2.41 Million
Q4 2018 Jan 18, 2019	SELL	$65.56 - $74.27 $118,335 - $134,057	-1,805 Reduced 5.21%	32,834 $2.38 Million
Q3 2018 Oct 17, 2018	SELL	$60.81 - $73.36 $6,324 - $7,629	-104 Reduced 0.3%	34,639 $2.54 Million
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $79,849 - $88,129	-1,387 Reduced 3.84%	34,743 $2.12 Million
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $102,073 - $115,406	-1,814 Reduced 4.78%	36,130 $2.17 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $32,208 - $34,482	-600 Reduced 1.56%	37,944 $2.17 Million
Q3 2017 Oct 24, 2017	BUY	$48.06 - $53.64 $1.85 Million - $2.07 Million	38,544	38,544 $2.06 Million

Others Institutions Holding ABT

# of Institutions

3,217

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.

Account